Antitrust concerns and the FDA approval process :  hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017. 
 Antitrust concerns and the Food and Drug Administration approval process 

 - 1 online resource (iv, 51 pages) 
<br/><br/> "Serial no. 115-27."  CRDP Program record. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Food and Drug Administration --Rules and practice.
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drugs--Testing.--United States<br/>Drug approval--United States.<br/>Drugs--Safety regulations--United States.<br/>Medical instruments and apparatus--Safety regulations--United States.<br/>Generic drugs--United States.<br/>Competition--United States.<br/>Antitrust law--United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.
<br/><br/><label>LC Class. No.: </label>KF27  / .J874 2017h 
<br/><br/><label>GPO Item No.: </label>1020-C (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.J 89/1:115-27 
<br/><br/><label>Report. No.: </label>Serial no. 115-27 (United States. Congress. House. Committee on the Judiciary)